1343 related articles for article (PubMed ID: 11206102)
21. Clinical benefits of trimetazidine in patients with recurrent angina.
Szwed H
Coron Artery Dis; 2004 May; 15 Suppl 1():S17-21. PubMed ID: 15179124
[TBL] [Abstract][Full Text] [Related]
22. Antianginal drug effects on normal, ischemic and scar myocardial segments in man.
Pfisterer M; Fridrich R; Burkart F
Scand J Clin Lab Invest Suppl; 1984; 173():65-73. PubMed ID: 6442004
[TBL] [Abstract][Full Text] [Related]
23. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
[TBL] [Abstract][Full Text] [Related]
24. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
[TBL] [Abstract][Full Text] [Related]
25. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
[TBL] [Abstract][Full Text] [Related]
26. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
[TBL] [Abstract][Full Text] [Related]
27. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.
Williams MJ; Odabashian J; Lauer MS; Thomas JD; Marwick TH
J Am Coll Cardiol; 1996 Jan; 27(1):132-9. PubMed ID: 8522686
[TBL] [Abstract][Full Text] [Related]
29. [Effect of acetyl-CoA C-acyltransferase inhibitor trimetazidine on parameters of global and local systolic and diastolic functions of left ventricular myocardium in patients with combined postinfarction ischemic syndrome].
Kastanaian AA; Nelasov NIu; Eroshenko OL; Kazarian NB; Drobotia NV
Kardiologiia; 2003; 43(9):21-7. PubMed ID: 14593366
[TBL] [Abstract][Full Text] [Related]
30. Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
Stanley WC; Marzilli M
Fundam Clin Pharmacol; 2003 Apr; 17(2):133-45. PubMed ID: 12667223
[TBL] [Abstract][Full Text] [Related]
31. Trimetazidine in Practice: Review of the Clinical and Experimental Evidence.
Dézsi CA
Am J Ther; 2016; 23(3):e871-9. PubMed ID: 25756467
[TBL] [Abstract][Full Text] [Related]
32. Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study.
Chazov EI; Lepakchin VK; Zharova EA; Fitilev SB; Levin AM; Rumiantzeva EG; Fitileva TB
Am J Ther; 2005; 12(1):35-42. PubMed ID: 15662290
[TBL] [Abstract][Full Text] [Related]
33. Clinical benefits of a metabolic approach in the cardiac rehabilitation of patients with coronary artery disease.
Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
Am J Cardiol; 2006 Sep; 98(5A):25J-33J. PubMed ID: 16931203
[TBL] [Abstract][Full Text] [Related]
34. [Combination of anti-angina drugs].
Silber S
Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
[TBL] [Abstract][Full Text] [Related]
35. Demand-induced ischemia in volume expanded isolated rat heart; the effect of dichloroacetate and trimetazidine.
Skierczynska A; Beresewicz A
J Physiol Pharmacol; 2010 Apr; 61(2):153-62. PubMed ID: 20436215
[TBL] [Abstract][Full Text] [Related]
36. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
[TBL] [Abstract][Full Text] [Related]
37. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
Leonardo F; Fragasso G; Rossetti E; Dabrowski P; Pagnotta P; Rosano GM; Chierchia SL
Cardiologia; 1999 Dec; 44(12):1065-9. PubMed ID: 10687257
[TBL] [Abstract][Full Text] [Related]
38. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
Grabczewska Z; Białoszyński T; Szymański P; Sukiennik A; Swiatkiewicz I; Koziński M; Kochman W; Grześk G; Kubica J
Cardiol J; 2008; 15(4):344-50. PubMed ID: 18698543
[TBL] [Abstract][Full Text] [Related]
39. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
Busse R; Bassenge E
Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
[TBL] [Abstract][Full Text] [Related]
40. [Value of the combination of trimetazidine (Vastarel 20 mg) with diltiazem (Tildiem 60 mg) in stable effort angina. A double-blind versus placebo multicenter study].
Lévy S
Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):203-12. PubMed ID: 7632029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]